Skip Content

Select your specialty for customized content

Genetic Counselors

The Ever-Expanding Potential
of Precision Medicine

Supporting genetic counselors and the broader oncology care team in removing barriers to complementary germline and tumor testing for comprehensive treatment planning.

Explore Biomarker Testing Guidelines

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) inform biomarker testing.

Access quick-reference flow charts of National Comprehensive Cancer Network® (NCCN®) biomarker testing recommendations by tumor type:

NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. 

aThis page contains content pertaining to non-small cell lung cancer (NSCLC) only.

NCCN, National Comprehensive Cancer Network.

The Germline Biomarkers Informing Treatment Options

NCCN and National Society of Genetic Counselors (NSGC) recommend genetic testing for inherited mutations for certain tumor types to help guide clinical decision making.

Access the latest information on common germline biomarkers, genetic testing, and biomarker prevalence:

Small mulberry breast icon

Breast Cancer

BRCA1/2
Small mulberry ovarian icon

Ovarian Cancer

HRD

BRCA1/2, BReast CAncer susceptibility gene 1/2; HER2, human epidermal growth factor receptor 2; HRD, homologous recombination deficiency; HRRm, homologous recombination repair gene mutation; NCCN, National Comprehensive Cancer Network; NSGC, National Society of Genetic Counselors.

How Genetic Counselors Can Improve Access to Precision Medicine

Expand access to genetic education and counseling for earlier, more informed cancer treatment decisions.

Collaborate to improve access to targeted treatment

Collaborate across the MDT to help address health inequities and optimize testing pathways.
Realize the potential
Woman on ipad talking to colleague
Lab screen showing microscopic image of stained tumor

Keep up with the pace of precision medicine

Wherever you may be in your biomarker testing journey, stay current on recent technology advances in cancer detection and emerging biomarkers to support precision medicine in your practice.
Discover latest developments

MDT, multidisciplinary team.

Solutions for Common Biomarker Testing Challenges

Find actionable solutions to address gaps in genetic counseling and testing for breast, ovarian, prostate, and pancreatic cancers. Counseling in the form of telehealth seeks to improve access for all and is one of many solutions explored across the biomarker testing journey.

Helpful Resources

Check out these featured resources, designed to help support genetic counselors in precision medicine and biomarker testing. 

Playlist icon

Add your preferred resources to My Favorites—a personalized list of resources to download and share with your peers or patients.

12:45 min

FOR HCPS

Leading the way: Approaches in biomarker testing for cancer treatment with Dana Clark

Watch Dana Clark, a genetic counselor, share her experience in standardizing biomarker testing in advanced ovarian cancer, involving pilot efforts, negotiating responsibilities, and implementing a user-friendly tracking system to improve biomarker testing rates.

3:58 min

FOR PATIENTS

Informed consent for genetic testing: Before the test, learn what to expect

Watch an overview of the informed consent process typically associated with genetic testing for cancer or hereditary cancer testing.

2:07 min

FOR PATIENTS

What your genetic test means for your family members

Share this brief explanation with your patients on how germline (or inherited) genetic mutations can provide information to other family members if they choose to pursue genetic testing for hereditary cancer risk.

Chatbox

If you have questions related to precision medicine, browse our FAQs to find quick answers.